These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26518400)

  • 1. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.
    Glanz JM; Newcomer SR; Daley MF; McClure DL; Baxter RP; Jackson ML; Naleway AL; Lugg MM; DeStefano F
    Vaccine; 2015 Nov; 33(48):6736-44. PubMed ID: 26518400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In process].
    Kreutzkamp B
    Med Monatsschr Pharm; 2016 Oct; 39(10):447-8. PubMed ID: 29979546
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.
    Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
    Pediatr Infect Dis J; 2014 Dec; 33(12):e320-9. PubMed ID: 24978857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in 10- to 14-year-old girls: open 6-year follow-up of an initial observer-blinded, randomized trial.
    Schwarz TF; Huang LM; Lin TY; Wittermann C; Panzer F; Valencia A; Suryakiran PV; Lin L; Descamps D
    Pediatr Infect Dis J; 2014 Dec; 33(12):1255-61. PubMed ID: 24978856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of aluminum in hair of Brazilian infants and correlation to aluminum-adjuvanted vaccine exposure.
    Bohrer D; Schmidt M; Marques RC; Dórea JG
    Clin Chim Acta; 2014 Jan; 428():9-13. PubMed ID: 24183841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes.
    Glanz JM; Clarke CL; Daley MF; Shoup JA; Hambidge SJ; Williams JTB; Groom HC; Kharbanda EO; Klein NP; Jackson LA; Lewin BJ; McClure DL; Xu S; DeStefano F
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34851413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.
    Glanz JM; Newcomer SR; Jackson ML; Omer SB; Bednarczyk RA; Shoup JA; DeStefano F; Daley MF
    Vaccine; 2016 Feb; 34 Suppl 1():A1-A29. PubMed ID: 26830300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?
    Tomljenovic L; Shaw CA
    J Inorg Biochem; 2011 Nov; 105(11):1489-99. PubMed ID: 22099159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children.
    Solares AR; Aragon CG; Pivaral RU; Prado-Cohrs D; Sales-Carmona V; Pellegrini M; Groth N
    J Infect Dev Ctries; 2014 Sep; 8(9):1160-8. PubMed ID: 25212080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.
    Brooks WA; Chang LJ; Sheng X; Hopfer R;
    Vaccine; 2015 Aug; 33(36):4610-7. PubMed ID: 26143615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.
    Moro ML; Nobilio L; Voci C; Di Mario S; Candela S; Magrini N;
    Vaccine; 2013 Feb; 31(10):1438-46. PubMed ID: 22885015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.
    Daley MF; Reifler LM; Glanz JM; Hambidge SJ; Getahun D; Irving SA; Nordin JD; McClure DL; Klein NP; Jackson ML; Kamidani S; Duffy J; DeStefano F
    Acad Pediatr; 2023; 23(1):37-46. PubMed ID: 36180331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.
    Mitkus RJ; King DB; Hess MA; Forshee RA; Walderhaug MO
    Vaccine; 2011 Nov; 29(51):9538-43. PubMed ID: 22001122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum in Vaccines: Addressing Parents' Concerns.
    Fernandez S
    Pediatr Ann; 2016 Jul; 45(7):e231-3. PubMed ID: 27403668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum vaccine adjuvants: are they safe?
    Tomljenovic L; Shaw CA
    Curr Med Chem; 2011; 18(17):2630-7. PubMed ID: 21568886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aluminium adjuvant exposure through vaccines in France in 2018].
    Angrand L; Elnar AA; Authier FJ; Gherardi RK; Crépeaux G
    Ann Pharm Fr; 2020 Mar; 78(2):111-128. PubMed ID: 32081303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infants' exposure to aluminum from vaccines and breast milk during the first 6 months.
    Dórea JG; Marques RC
    J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):598-601. PubMed ID: 20010978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.